Precision medicine has led to the identification of new biological drugs and targets for personalized treatments. A limitation of biological drugs relies on their difficulties for overcoming biological barriers. However, recent developments on drug delivery are opening new avenues that may soon make feasible the oral administration of biologics. In article number 1901935, María José Alonso and co‐workers provide an overview of the current situation, future prospects, barriers to clinical translation, and identified opportunities for advancement in this field.

中文翻译：

---

口服药物递送：精密医学生物制剂的口服递送（Adv。Mater。13/2020）

精密医学已导致鉴定新的生物药物和个性化治疗的靶标。生物药物的局限性在于其克服生物障碍的困难。但是，药物输送的最新发展开辟了新途径，可能很快使口服生物制剂成为可能。玛丽亚·何塞·阿隆索（MaríaJoséAlonso）和他的同事们在编号1901935中概述了目前的情况，未来的前景，临床翻译的障碍，并确定了该领域的发展机会。